Please ensure Javascript is enabled for purposes of website accessibility

Where the Real Value Is Now

By Dan Caplinger – Updated Apr 6, 2017 at 12:49AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Look to forgotten stocks for great opportunities.

If you can anticipate where the investing crowd will go next rather than simply follow the herd, your portfolio will perform a lot better. So when you're seeking attractive investments, looking back at past results can help you -- but not in the way that most people use them.

Looking at the rally
Overall, the stock market has seen some amazing gains over the past six months. Although you could chalk up the initial bounce off the early March lows to relief that the financial system had avoided imminent collapse, the gains during the second and third quarters also incorporated a strengthening belief that the economy would improve and that businesses would begin to prosper again.

Yet some industries have recovered more strongly than others. Here's a comparison of how stocks in different industries have performed over the past six months:

Industry

2nd-Quarter Return

3rd-Quarter Return

Consumer Discretionary

18.2%

19.2%

Consumer Staples

10.1%

11.5%

Energy

13.4%

12.9%

Financial

35.8%

25.5%

Health Care

8.9%

9.5%

Industrial

19.3%

21.0%

Materials

16.9%

20.6%

Technology

16.8%

15.1%

Utilities

9.9%

6.1%

Source: Morningstar. Returns are for Select Sector SPDR ETF for each industry.

As you'd probably expect, financial stocks have soared as the immediate threat to their industry began to subside. Meanwhile, stocks in traditionally defensive industries, such as consumer staples and utilities, have held back during the rally, and health-care stocks have suffered as their industry has come under intense scrutiny as part of the debate over government health-care reform.

Is the obvious strategy the best one?
The obvious value strategy is to concentrate on the one or two worst-performing sectors and look for bargains among them. Several utility stocks look like great values right now, and companies such as Johnson & Johnson (NYSE:JNJ) are making the best of health-care bargains by ramping up acquisitions, following in the footsteps of drug giants Merck (NYSE:MRK) and Pfizer (NYSE:PFE).

That strategy makes doing research a lot easier. If you think an entire industry is undervalued, you can keep things simple by buying a sector ETF that invests in a wide range of industry stocks. Conversely, if you want to drill down further to identify the best individual stocks, it still gives you a way to focus your efforts so you don't have to do research on hundreds of different companies.

Building a better portfolio
The problem with that approach, though, is that you end up with an undiversified portfolio concentrated in just a few sectors. And while concentration can juice returns if your timing is good, just because a sector does badly in one quarter doesn't mean it's going to pop back up during the next.

That's why I think the better choice is to mix stocks from different sectors. If you want to get fancy, then invest a bit more in stocks from beaten-down industries, but make sure your portfolio includes some companies from better-performing sectors as well. Even where stock prices have increased dramatically, you can still find attractive values. Here's a sample of stocks that look relatively cheap compared with their peers and the overall market.

Stock

Industry

Return 3/31 to 9/30

P/E Ratio

Chevron (NYSE:CVX)

Energy

6.8%

8.4

Oracle (NASDAQ:ORCL)

Software

13.1%

18.3

FMC

Basic Materials-Chemicals

31.0%

15.2

Raytheon (NYSE:RTN)

Industrial-Defense

25.0%

10.5

Kraft Foods (NYSE:KFT)

Consumer Staples

20.5%

12.6

Source: Yahoo! Finance.

Stocks like these can help you round out a diverse stock portfolio while maintaining a value-oriented investing style. That should give you good results over the long haul, regardless of whether the economy continues on its upward track or suffers a setback in the coming months.

Stick with value
At times like these, following a value-investing strategy takes a lot of discipline. When others are seeing big rewards from sticking with high-momentum stocks that have risen the furthest since the rally began, you might believe that value investing has lost its usefulness.

The key, though, is understanding that value investing isn't just about bottom-hunting. Stocks with true value can be found anywhere, even within industries that have performed extremely well. If you can successfully smoke out those values, then you'll be able to build an overall stock portfolio that will provide both good growth prospects and protection against downturns. That's a risk-reward combination you shouldn't miss.

Do you think you're a smart investor? Read why Anand Chokkavelu thinks you might be too smart to get rich.

Fool contributor Dan Caplinger looks everywhere for cheap stocks. He doesn't own shares of the companies mentioned in this article. Pfizer is a Motley Fool Inside Value selection. Johnson & Johnson is an Income Investor recommendation. Try any of our Foolish newsletter services free for 30 days. The Fool's disclosure policy always gives you real value.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Merck & Co., Inc. Stock Quote
Merck & Co., Inc.
MRK
$86.18 (-0.69%) $0.60
Kraft Foods Group, Inc. Stock Quote
Kraft Foods Group, Inc.
KRFT.DL
Chevron Corporation Stock Quote
Chevron Corporation
CVX
$140.96 (-2.63%) $-3.81
Johnson & Johnson Stock Quote
Johnson & Johnson
JNJ
$165.70 (-0.61%) $-1.02
Pfizer Inc. Stock Quote
Pfizer Inc.
PFE
$43.83 (-0.57%) $0.25
Oracle Corporation Stock Quote
Oracle Corporation
ORCL
$63.45 (-1.70%) $-1.10
Raytheon Company Stock Quote
Raytheon Company
RTN

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/26/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.